12 Health Care Stocks Moving In Monday's Intraday Session
I'm LongbridgeAI, I can summarize articles.During Monday's intraday session, several healthcare stocks experienced significant volatility. Gainers included Redhill Biopharma (up 69.4%), CollPlant Biotechnologies (up 24.35%), and Cadrenal Therapeutics (up 17.2%). Conversely, notable losers featured Aethlon Medical (down 18.8%), AIM ImmunoTech (down 17.88%), and NuCana (down 17.62%). The report highlights specific price movements and market capitalizations for these listed companies.
Gainers
- Redhill Biopharma (NASDAQ:RDHL) stock increased by 69.4% to $1.12 during Monday's regular session. The company's market cap stands at $4.0 million.
- CollPlant Biotechnologies (NASDAQ:CLGN) shares increased by 24.35% to $0.45. The market value of their outstanding shares is at $6.7 million.
- Cadrenal Therapeutics (NASDAQ:CVKD) stock moved upwards by 17.2% to $1.8. The market value of their outstanding shares is at $5.4 million.
- BioVie (NASDAQ:BIVI) shares rose 11.59% to $2.41. The company's market cap stands at $18.2 million.
- Cosmos Health (NASDAQ:COSM) stock rose 10.85% to $0.25. The market value of their outstanding shares is at $22.6 million.
- Polyrizon (NASDAQ:PLRZ) shares rose 9.77% to $14.43. The company's market cap stands at $27.3 million.
Losers
- Aethlon Medical (NASDAQ:AEMD) shares fell 18.8% to $2.02 during Monday's regular session. The company's market cap stands at $1.7 million.
- AIM ImmunoTech (AMEX:AIM) stock declined by 17.88% to $0.21. The market value of their outstanding shares is at $7.8 million.
- NuCana (NASDAQ:NCNA) shares fell 17.62% to $1.45. The market value of their outstanding shares is at $7.3 million.
- YD Bio (NASDAQ:YDES) shares fell 17.09% to $3.98. The company's market cap stands at $339.9 million.
- Jupiter Neurosciences (NASDAQ:JUNS) shares decreased by 16.28% to $3.5. The company's market cap stands at $5.5 million.
- Tenax Therapeutics (NASDAQ:TENX) stock fell 16.2% to $1.78. The market value of their outstanding shares is at $56.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.